Should We Include Connection Domain Mutations of HIV-1 Reverse Transcriptase in HIV Resistance Testing?

Matthias Götte

doi:10.1371/journal.pmed.0040346

Loading metrics

Open Access

Perspective Perspectives are commissioned from an expert and discuss the clinical practice or public health implications of a published study. The original publication must be freely available online.

See all article types »

Should We Include Connection Domain Mutations of HIV-1 Reverse Transcriptase in HIV Resistance Testing?

Matthias Götte

* E-mail: matthias.gotte@mcgill.ca
⨯

Should We Include Connection Domain Mutations of HIV-1 Reverse Transcriptase in HIV Resistance Testing?

Matthias Götte

Published: December 1, 2007
https://doi.org/10.1371/journal.pmed.0040346

About the Authors

Matthias Götte: * E-mail: matthias.gotte@mcgill.ca

Competing Interests

The author has declared that no competing interests exist.

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Ribonucleases
Is the Subject Area "Ribonucleases" applicable to this article?

Thanks for your feedback.
HIV-1
Is the Subject Area "HIV-1" applicable to this article?

Thanks for your feedback.
HIV
Is the Subject Area "HIV" applicable to this article?

Thanks for your feedback.
Virus testing
Is the Subject Area "Virus testing" applicable to this article?

Thanks for your feedback.
Antiretroviral therapy
Is the Subject Area "Antiretroviral therapy" applicable to this article?

Thanks for your feedback.
Substitution mutation
Is the Subject Area "Substitution mutation" applicable to this article?

Thanks for your feedback.
Antiretrovirals
Is the Subject Area "Antiretrovirals" applicable to this article?

Thanks for your feedback.
Genotyping
Is the Subject Area "Genotyping" applicable to this article?

Thanks for your feedback.